Oxford Immunotec Global PLC EBITDA margin
Cos'è EBITDA margin di Oxford Immunotec Global PLC?
EBITDA margin di Oxford Immunotec Global PLC è -5.69%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Health Care settore su NASDAQ rispetto a Oxford Immunotec Global PLC
Aziende con ebitda margin simili a Oxford Immunotec Global PLC
- Hudson Technologies ha EBITDA margin di -5.73%
- Wayfair Inc ha EBITDA margin di -5.72%
- Toutabo SA ha EBITDA margin di -5.71%
- Rohit Ferro-Tech ha EBITDA margin di -5.70%
- Rigel Pharmaceuticals ha EBITDA margin di -5.69%
- Apollo Global Management Inc ha EBITDA margin di -5.69%
- Oxford Immunotec Global PLC ha EBITDA margin di -5.69%
- Silver Bear Resources Plc ha EBITDA margin di -5.68%
- Canyon Creek Food ha EBITDA margin di -5.67%
- Pcas Sa ha EBITDA margin di -5.63%
- Tianjin TEDA Biomedical Engineering ha EBITDA margin di -5.63%
- BurgerFi International ha EBITDA margin di -5.62%
- China Southern Airlines ha EBITDA margin di -5.62%